NCT03895346

Brief Summary

This study aims to determine the feasibility and acceptability of conducting a larger randomized clinical trial to test whether individuals with MCI can benefit from mental training programs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 29, 2019

Completed
12 days until next milestone

Study Start

First participant enrolled

April 10, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

September 15, 2022

Status Verified

September 1, 2022

Enrollment Period

12 months

First QC Date

March 26, 2019

Last Update Submit

September 14, 2022

Conditions

Keywords

MindfulnessMeditationImagingMRI

Outcome Measures

Primary Outcomes (3)

  • Recruitment feasibility

    Number of subjects recruited within 6 months; determine the number of people excluded for each inclusion/exclusion criterion; assessing reasons why eligible people decide not to enroll.

    6 months

  • Retention

    Remaining in the study for the full duration of all testing time points (yes/no). Quantify the reasons for dropout

    6 months

  • Adherence to study protocol

    Number of classes attended; number of times the subject practiced prescribed activities at home; number of people who complete each test/assessment.

    6 months

Study Arms (2)

Mindfulness

EXPERIMENTAL

Class meeting three times a week for six months, led by a certified mindfulness meditation instructor. Includes instruction and practice on techniques such as breathing, body scan, physical sensations, and yoga.

Behavioral: Mindfulness

Brain Games and Puzzles

ACTIVE COMPARATOR

Class meeting three times a week for six months, led by a qualified instructor. Includes teaching and practice of puzzles such as word searches, crossword puzzles, Sudoku, and KenKen.

Behavioral: Brain Games and Puzzles

Interventions

MindfulnessBEHAVIORAL

Mindfulness meditation is a technique of sustained attention and focus, involving preventing the mind from wandering from the meditative object (i.e. breath or body sensations)

Also known as: Meditation
Mindfulness

Intervention will include the instruction and practice of puzzles such as word searches, crossword puzzles, Sudoku, and KenKen.

Brain Games and Puzzles

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CDR (clinical dementia rating) of 0.5
  • years of age
  • Able to speak, read, and understand English
  • Willing to participate in a 6 month study and undergo 2 MRI scans at Mass General Hospital
  • A score suggesting Mild Cognitive Impairment on the Telephone Interview for Cognitive Status (TICS)
  • A Mini Mental State Exam adjusted for age and education of 24 to 30
  • Stable medications for at least 30 days
  • Subjects with well-controlled vascular risk factors such as treated hypertension, treated hyperlipidemia or well-controlled Type II diabetes (glucose levels \< 250) will be included.
  • Subjects with a history of cerebrovascular problems but have no persistent neurological deficits will be included
  • Available for scheduled class times for both study courses
  • Able to complete 40 minutes of homework per day during the 6-month course
  • CDR (clinical dementia rating) of 0.5

You may not qualify if:

  • CDR score other than 0.5
  • Cardiovascular disease, stroke, congestive heart failure
  • Has surgical aneurysm clips, neurostimulator, implanted pumps, metal fragments in eyes, cardiac pacemaker, non-removable nitroglycerin patch, non-MRI compatible cochlear implants, any other non-MRI compatible metal in body
  • Has permanent bridgework in upper mouth that could interfere with MRI scan
  • Active hematological, renal, pulmonary, endocrine, or hepatic disorders
  • Uncontrolled high blood pressure
  • Uncontrolled diabetes or insulin-treated diabetes (diabetes that is controlled with no more than one oral medication will be allowed)
  • A history of neurological disease or injury, including a history of seizures or significant head trauma (i.e. extended loss of consciousness, bleeding in the brain, Parkinson's disease, stroke)
  • Received treatment for cancer within the last year (skin cancer will be allowed as will any cancer more than 2 years since the last treatment)
  • Diagnosis of schizophrenia, PTSD, bipolar disorder, or psychotic disorder at any point during lifetime
  • Any axis I psychiatric disorder within the last 12 months
  • Weighs more than 350 pounds
  • Neurological or medical conditions that would interfere with study procedures or confound results, such as conditions that alter cerebral blood flow or metabolism
  • Unstable medications or on medications with CNS effects including cholinesterase inhibitors, memantine, and antidepressants
  • Use of psychotropic medications within 12 months prior to the study
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02119, United States

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

MindfulnessMeditation

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesMind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation Therapy

Study Officials

  • Sara Lazar, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigator and outcomes assessors will be masked to the group assignment of participants (mindfulness or brain games and puzzles).
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Research Scientist

Study Record Dates

First Submitted

March 26, 2019

First Posted

March 29, 2019

Study Start

April 10, 2019

Primary Completion

March 30, 2020

Study Completion

December 31, 2021

Last Updated

September 15, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations